Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason J Kwon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Communications Chemistry|June 15, 2026
Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitorsLongjiang Qiao, Xinyu Li, Shuaishuai Xing, et al.
Molecular Therapy. Methods & Clinical Development|January 20, 2018
Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer MiceKayla A Quirin, Jason J Kwon, Arafat Alioufi, et al.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Nature|July 13, 2022
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complexJason J Kwon, Behnoush Hajian, Yuemin Bian, et al.
Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J Kwon, Julien Dilly, Shengwu Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Communications Chemistry|June 15, 2026
Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitorsLongjiang Qiao, Xinyu Li, Shuaishuai Xing, et al.
Molecular Therapy. Methods & Clinical Development|January 20, 2018
Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer MiceKayla A Quirin, Jason J Kwon, Arafat Alioufi, et al.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Nature|July 13, 2022
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complexJason J Kwon, Behnoush Hajian, Yuemin Bian, et al.
Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activityJason J Kwon, Julien Dilly, Shengwu Liu, et al.
Pageof 2